Paul Effler

Paul Effler is a Clinical Professor at the Department of Pathology & Laboratory Medicine, affiliated with the UWA Medical School at The University of Western Australia. His research focuses on vaccine safety, infectious disease epidemiology, and public health surveillance, particularly in respiratory infections like influenza and RSV. He has contributed to studies evaluating nirsevimab efficacy against RSV, SARS-CoV-2 variant dynamics, and meningococcal vaccination programs in Western Australia.

Effler's work aligns with UN Sustainable Development Goals related to good health and well-being. He has supervised 3 research projects and published widely on topics including vaccine safety, pediatric immunization programs, and outbreak control strategies. His publications have appeared in journals like Nature Medicine and Journal of Infection.

Key research interests include influenza vaccination strategies, adverse event monitoring, and population health interventions. His recent studies analyze RSV prophylaxis outcomes, viral evolution patterns, and the impact of vaccination programs during epidemics.